What is the difference between Ixifi and Remicade?
Medically reviewed by Drugs.com. Last updated on Sep 7, 2023.
Ixifi (infliximab-qbtx) is a tumor necrosis factor (TNF) blocker that is biosimilar to Remicade (infliximab).
Biosimilars are approved through an abbreviated licensure pathway for biological products that are shown to be interchangeable with an already FDA-approved biological product.
What Are Biosimilars? Top Facts You May Not Know
Ixifi and Remicade are used for the treatment of Crohn’s disease, ulcerative colitis, rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and plaque psoriasis.
Ixifi is not interchangeable with Remicade at the pharmacy level unless specifically noted by the prescribing doctor.
For more information, see Comparing Ixifi vs Remicade
Related medical questions
- What does psoriasis look like?
- How do you get psoriasis and is it contagious?
- How does Tremfya work to treat plaque and psoriatic arthritis?
- How does Ilumya work to treat psoriasis?
- Prednisone: What are 12 Things You Should Know?
- Where should you not use triamcinolone acetonide cream?
- What are the new drugs for plaque psoriasis?
- Why should I take folic acid with methotrexate?
- How do you use clobetasol propionate on your scalp?
- What is a substitute for fluocinonide cream?
- Is triamcinolone acetonide an antifungal cream?
Drug information
Related support groups
- Psoriasis (95 questions, 301 members)
- Remicade (23 questions, 185 members)
- Infliximab (8 questions, 16 members)
- Ixifi (5 questions, 3 members)
- Rheumatoid Arthritis (306 questions, 1,303 members)
- Psoriatic Arthritis (75 questions, 272 members)
- Ulcerative Colitis (56 questions, 184 members)
- Crohn's Disease (45 questions, 279 members)
- Plaque Psoriasis (81 questions, 69 members)
- Ankylosing Spondylitis (44 questions, 212 members)
- Inflammatory Bowel Disease (12 questions, 55 members)
- Toxic Epidermal Necrolysis (3 questions, 7 members)